Lalitha’s research at CSER is in the area of bio-risk, with a particular emphasis on regulation and governance. She investigates risks – real or perceived – surrounding emerging biotechnologies such as synthetic biology. Before joining CSER, Lalitha worked within the University of Cambridge and Edinburgh’s Arsenic Biosensor Collaboration where she developed strategy to take this novel synthetic biology product from bench to field, focusing on the international regulatory landscape and Responsible Research and Innovation. Following this, she held a fellowship at King’s College London investigating the opportunities and challenges facing emerging biotechnologies seeking to tackle global health challenges. Lalitha’s PhD research, also at the University of Cambridge, used a combination of bioinformatic, next-generation sequencing and molecular biology tools to explore host-cell metabolic and microRNA changes following infection by the pathogenic parasite Toxoplasma gondii.
[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.